CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 108 filers reported holding CYMABAY THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,688,348 | -27.5% | 180,305 | -46.8% | 1.24% | -26.7% |
| Q2 2023 | $3,710,320 | +22.3% | 338,842 | -2.6% | 1.70% | -31.3% |
| Q1 2023 | $3,032,694 | +22.3% | 347,786 | -12.0% | 2.47% | +67.9% |
| Q4 2022 | $2,478,732 | +79.1% | 395,332 | 0.0% | 1.47% | +86.2% |
| Q3 2022 | $1,384,000 | +18.7% | 395,332 | 0.0% | 0.79% | +12.2% |
| Q2 2022 | $1,166,000 | +80.8% | 395,332 | +90.7% | 0.70% | +71.7% |
| Q1 2022 | $645,000 | -3.6% | 207,307 | +77.9% | 0.41% | -4.0% |
| Q4 2020 | $669,000 | – | 116,519 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,641,804 | $7,454,000 | 6.54% |
| COMMODORE CAPITAL LP | 2,983,513 | $13,545,000 | 5.40% |
| Foresite Capital Management IV, LLC | 1,787,094 | $8,113,000 | 0.97% |
| Avoro Capital Advisors LLC | 10,300,000 | $46,762,000 | 0.81% |
| Boxer Capital, LLC | 4,000,000 | $18,160,000 | 0.62% |
| Sio Capital Management, LLC | 562,339 | $2,553,000 | 0.52% |
| ACUTA CAPITAL PARTNERS, LLC | 315,341 | $1,432,000 | 0.52% |
| CM Management, LLC | 150,000 | $681,000 | 0.51% |
| APIS CAPITAL ADVISORS, LLC | 120,000 | $545,000 | 0.50% |
| Versant Venture Management, LLC | 543,753 | $2,469,000 | 0.48% |